Skip to content

Effects of Legumes Consumption on Weight Reduction

Effects of Legumes Consumption on Weight Reduction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04392882
Enrollment
400
Registered
2020-05-19
Start date
2011-03-01
Completion date
2013-03-31
Last updated
2021-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese

Keywords

legumes, obesity, body weight, adiponectin, 8-epi-PGF2α, insulin resistance

Brief summary

This is a 12-week, randomized nutritional intervention study to determine the effect of legumes consumption on body weight in obese subjects.

Interventions

BEHAVIORALLegume enriched diet group

* Replacing 1/3 refined rice intake with legumes three times per day * Vegetable intake at least six units (30-70 g/unit) per day for sufficient dietary fiber intake * Regular 30-min walk after dinner each day

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. Male and female volunteers between the ages of 20 to 70 years 2. Body mass index (BMI) of 25 kg/m2 or higher (based on Asia-Pacific guideline) 3. Volunteers who have agreed to participate in the study and provided a written content by him/herself

Exclusion criteria

1. Those with type 2 diabetes, cardiovascular disease, psychiatric problems, thyroid disorders, liver or kidney disease 2. Those under the use of any medications (antihypertensive, lipid-lowering, antiplatelet, antidiabetic, etc.).

Design outcomes

Primary

MeasureTime frameDescription
Changes of BMI12 weeksChanges of weight in kilograms was assessed before and after the intervention. Changes of height in meters was assessed before and after the intervention. Weight and height were combined to report BMI in kg/m\^2.
Changes of Insulin Resistance (IR)12 weeksChanges of fasting serum glucose in mmol/L was assessed before and after the intervention. Changes of fasting insulin in μIU/mL was assessed before and after the intervention. Fasting insulin and fasting glucose were combined to report IR using the following equation: homeostasis model assessment (HOMA)-IR=\[fasting insulin (μIU/mL)×fasting glucose (mmol/L)\] /22.5.
Changes of lipid profiles12 weeksTriglyceride in mg/dL was assessed before and after the intervention. Total-cholesterol in mg/dL was assessed before and after the intervention. HDL-cholesterol in mg/dL was assessed before and after the intervention. LDL-cholesterol was indirectly estimated using the friedewald formula: LDL-cholesterol= total-cholesterol-\[HDL-cholesterol+(triglycerides/5)\].
Changes of serum high C-reactive12 weeksChanges of serum high C-reactive in mg/L was assessed before and after the intervention.
Changes of urinary 8-epi-PGF2α12 weeksChanges of urinary 8-epi-PGF2α in pg/mg creatinine was assessed before and after the intervention.
Changes of adiponectin12 weeksChanges of adiponectin in ng/mL was assessed before and after the intervention.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026